CELIA ROSALES: Open Payments
NPI 1043234214 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$200 in 11 payments from 9 companies in 2025. Trend: 2023 $379 · 2024 $337 · 2025 $200
Food & beverage: $200
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $35 |
| SHIELD THERAPEUTICS INC | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $22 |
| Abbott Laboratories | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| SCPHARMACEUTICALS INC. | 1 | $14 |
Products named: ACCRUFER, Kerendia, Wegovy, FREESTYLE LIBRE 3, LEQVIO, JARDIANCE, REXULTI, MOUNJARO.
Industry payments across TX — which companies pay providers there.
